Women's Health
Molecular biology reference lab — HPV, STIs, gynecological health, fetal sexing and genetics, with nationwide logistics.
What we deliver
A complete molecular portfolio for laboratories serving women's health: 28 HPV genotypes, multiplex panels for STIs, bacterial vaginosis and candidiasis, fetal sexing from week 8, and genetic panels (BRCA1/2, thrombophilia, endometriosis, PCOS). Average 4-day turnaround with dedicated scientific support.
- HPV — 28 genotypes, high and low risk
- Multiplex STI panels in a single run
- Bacterial vaginosis, candidiasis, vaginal microbiome
- Fetal sexing from week 8 — 3-day result
- BRCA1/2, thrombophilia, endometriosis, PCOS
- Nationwide logistics and partner portal
HPV-DNA testing: genotyping, self-collection and implementation
28 genotypes, how it differs from cytology, 4-day turnaround and the workflow for clinics and labs.
The full technical documentation lives on the dedicated landing page.
Case studies, timelines, markers, protocols and scope form.
Other services
Pre-Clinical Research
A reference in innovation for pre-clinical assays — everything your study needs in one place.
Validation of Diagnostic & Pharmaceutical Products
Development and validation of diagnostic and pharmaceutical products with absolute regulatory compliance.
Cell Line Authentication
Precision and reliability for safe pre-clinical results — 16+ STR markers analyzed in 10 days.
Base for CROs
Add high-level R&D engineering and ANVISA/FDA infrastructure to your CRO's portfolio — with no fixed costs.